IA VERSUS K-D ANTIGENS IN IMMUNOLOGICAL ENHANCEMENT OF TUMOR ALLOGRAFTS

被引：23

作者：

DUC, HT ^{[1
]}

KINSKY, RG ^{[1
]}

VOISIN, GA ^{[1
]}

机构：

[1] HOP ST ANTOINE,F-75012 PARIS,FRANCE

来源：

TRANSPLANTATION | 1978年 / 25卷 / 04期

关键词：

D O I：

10.1097/00007890-197804000-00005

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：182 / 187

页数：6

共 11 条

[1]

DAVID CS, 1976, TRANSPLANT REV, V30, P322

[2] WHAT ABROGATES HEART-TRANSPLANT REJECTION IN IMMUNOLOGICAL ENHANCEMENT [J].

DAVIES, DAL ;

ALKINS, BJ .

NATURE, 1974, 247 (5439) :294-297

[3]

DAVIES DAL, 1976, TRANSPLANT REV, V30, P18

[4] EFFECTS OF ERYTHROCYTE-ABSORBED H-2 ALLOANTISERA ON MIXED LYMPHOCYTE CULTURE REACTIONS [J].

FISH, F ;

STAINES, NA ;

SWORN, JL ;

DAVIES, DAL .

TRANSPLANTATION, 1976, 22 (06) :551-558

[5]

GORER PA, 1956, TRANSPLAN B, V3, P142

[6]

GORER PA, 1954, CANCER RES, V14, P651

[7]

HAUPTFELD V, 1974, J IMMUNOL, V113, P181

[8] THE SURVIVAL OF HOMOGRAFTS IN MICE PRETREATED WITH ANTISERA TO MOUSE TISSUE [J].

KALISS, N .

ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1957, 64 (05) :977-993

[9]

MOLLER G, 1963, J NATL CANCER I, V30, P1177

[10]

OUCHTERLONY O, 1949, ACTA PATHOL MIC SC, V26, P507

← 1 2 →